Detalhe da pesquisa
1.
Efficacy and safety of curcumin in maintaining remission during disease-modifying antirheumatic drug withdrawal in rheumatoid arthritis at 52 weeks: a phase III double-blind, randomized placebo-controlled trial.
Rheumatol Int
; 43(12): 2193-2200, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37650921